Home/Pipeline/Immuneel‑CAR‑NHL

Immuneel‑CAR‑NHL

Non‑Hodgkin Lymphoma

PreclinicalActive

Key Facts

Indication
Non‑Hodgkin Lymphoma
Phase
Preclinical
Status
Active
Company

About Immuneel Therapeutics

India‑based biotech delivering low‑cost CAR‑T therapies for blood cancers.

View full company profile

Therapeutic Areas

Other Non‑Hodgkin Lymphoma Drugs

DrugCompanyPhase
Rituximab BiosimilarBio Usawa BiotechnologyPreclinical